|Bid||0.2746 x 800|
|Ask||0.3100 x 3100|
|Day's range||0.2827 - 0.2890|
|52-week range||0.1710 - 1.3400|
|Beta (5Y monthly)||2.07|
|PE ratio (TTM)||N/A|
|Earnings date||22 Feb 2023 - 27 Feb 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||4.00|
NantHealth ( NASDAQ:NH ) Third Quarter 2022 Results Key Financial Results Revenue: US$16.6m (up 16% from 3Q 2021). Net...
MORRISVILLE, N.C., November 03, 2022--NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today reported financial results for its third quarter ended September 30, 2022.
MORRISVILLE, N.C., October 31, 2022--NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2022 third quarter on Thursday, November 3, 2022, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.